|
TBL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.617300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.299200E-03 |
| Normal-vs-Stage2 |
3.209500E-02 |
| Normal-vs-Stage3 |
4.907900E-02 |
| Normal-vs-Stage4 |
1.898160E-02 |
| Stage1-vs-Stage2 |
5.105600E-01 |
| Stage1-vs-Stage3 |
8.145400E-01 |
| Stage1-vs-Stage4 |
7.036800E-01 |
| Stage2-vs-Stage3 |
4.885000E-01 |
| Stage2-vs-Stage4 |
8.123400E-01 |
| Stage3-vs-Stage4 |
6.283200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.977660E-04 |
| Normal-vs-AfricanAmerican |
9.052200E-02 |
| Normal-vs-Asian |
8.000000E-03 |
| Caucasian-vs-AfricanAmerican |
8.339800E-01 |
| Caucasian-vs-Asian |
8.743400E-01 |
| AfricanAmerican-vs-Asian |
9.055600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.852190E-02 |
| Normal-vs-Female |
6.157900E-04 |
| Male-vs-Female |
6.502200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.001600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.364000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.342500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.739000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.140600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.474400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.884200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.733600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.695200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.755000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.604000E-01 |
| Classical-VS-Follicular |
1.138110E-02 |
| Classical-VS-Other |
6.987800E-01 |
| Classical-VS-Normal |
5.78289999999537E-05 |
| Tall-VS-Follicular |
5.768000E-01 |
| Tall-VS-Other |
9.397000E-01 |
| Tall-VS-Normal |
3.975200E-01 |
| Follicular-VS-Other |
6.309600E-01 |
| Follicular-VS-Normal |
6.172600E-01 |
| Other-VS-Normal |
5.774400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.187700E-04 |
| Normal-vs-N1 |
1.140240E-01 |
| N0-vs-N1 |
9.062600E-01 |
|
|
